Company: LENZ
Filing Date: 2025-11-05
Form Type: 10-Q
Source: 0001815776-25-000071
Chunk: 342

Company: LENZ Therapeutics, Inc.
Filing Date: 2025-11-05
Form: 10-Q
Item: Part I, Item 8
Chunk 342
---
 other comprehensive income (loss) is the result of unrealized gains and losses on marketable securities.Segment ReportingOperating segments are defined as components of an entity about which separate discrete information is available for evaluation by the chief operating decision maker (“CODM”), or decision-making group, in deciding how to allocate resources and in assessing performance. The Company’s Chief Executive Officer acts as the CODM. The CODM views the Company’s operations and manages its business as one operating segment operating exclusively in the United States. The Company’s singular focus is on the development and commercialization of innovative therapies to improve vision, and has generated limited revenue since inception. The CODM utilizes consolidated net loss to monitor budgeted versus actual results, and to assess the overall financial performance and operational efficiency of the business. The CODM manages and allocates resources to the operations of the Company on an entity-wide basis using net loss as the primary performance measure. Asset information provided to the CODM is consistent with those reported on the condensed consolidated balance sheets and are attributable to the United States.

14

The table below shows a reconciliation of the Company's net loss, including the significant expense categories regularly provided to and reviewed by the CODM, as computed under U.S. GAAP, to the Company's total consolidated net loss in the condensed consolidated statements of operations:Three Months Ended September 30,Nine Months Ended September 30,2025202420252024Revenue:License revenue$12,500 $— $17,500 $— Total revenue12,500 — 17,500 — Operating expenses:Selling, general, and administrative expenses(1)24,389 5,279 44,277 16,249 Research and development expenses(1)3,529 5,475 17,029 22,401 Share-based compensation expense3,469 2,191 8,869 4,735 Total operating expenses31,387 12,945 70,175 43,385 Loss from operations(18,887)(12,945)(52,675)(43,385)Other income (expense):Other income (expense)(14)(6)174 281 Interest income2,201 2,736 6,770 5,987 Net loss before income taxes(16,700)(10,215)(45,731)(37,117)Income tax expense— — 500 — Net loss$(16,700)$(10,215)